Global Cognitive and Memory Enhancer Drugs Market Analysis, Service Type, Industry Overview, Sales Revenue and Growth 2018-2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Oct-2018   |    Format :PDF   |    Number of Pages : 110
This report studies the global market size of Cognitive and Memory Enhancer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cognitive and Memory Enhancer Drugs in these regions.
This research report categorizes the global Cognitive and Memory Enhancer Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
The major factors that drive the growth of the global cognitive and memory enhancer drugs market include surge in geriatric population and rise in prevalence of neurological & memory-related disorders. Furthermore, the benefits offered by cognitive drugs such as improved memory and reasoning propel the market growth. However, ethical issues related to the use of these drugs restrict the market growth.
In 2017, the global Cognitive and Memory Enhancer Drugs market size was 4130 million US$ and is forecast to 8030 million US in 2025, growing at a CAGR of 8.7% from 2018. The objectives of this study are to define, segment, and project the size of the Cognitive and Memory Enhancer Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Cognitive and Memory Enhancer Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Cognitive and Memory Enhancer Drugs include
    Pfizer Inc.
    Eisai Co., Ltd.
    Allergan, Inc.
    Novartis AG
    Shire
    Johnson & Johnson
    Takeda Pharmaceutical Company Limited
    AlternaScript LLC
    Cephalon, Inc.
    Ceretropic.

Market Size Split by Type
    Aricept
    Exelon
    Namenda
    Razadyne
    Provigil
    Ritalin
    Adderall
    Others
Market Size Split by Application
    Disease Treatment
    Academic Performance
    Athletic Performance
    Others

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Cognitive and Memory Enhancer Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Cognitive and Memory Enhancer Drugs market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Cognitive and Memory Enhancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Cognitive and Memory Enhancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Cognitive and Memory Enhancer Drugs submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cognitive and Memory Enhancer Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cognitive and Memory Enhancer Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Cognitive and Memory Enhancer Drugs Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type
        1.4.2 Aricept
        1.4.3 Exelon
        1.4.4 Namenda
        1.4.5 Razadyne
        1.4.6 Provigil
        1.4.7 Ritalin
        1.4.8 Adderall
        1.4.9 Others
    1.5 Market by Application
        1.5.1 Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Application
        1.5.2 Disease Treatment
        1.5.3 Academic Performance
        1.5.4 Athletic Performance
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Cognitive and Memory Enhancer Drugs Market Size
        2.1.1 Global Cognitive and Memory Enhancer Drugs Revenue 2016-2025
        2.1.2 Global Cognitive and Memory Enhancer Drugs Sales 2016-2025
    2.2 Cognitive and Memory Enhancer Drugs Growth Rate by Regions
        2.2.1 Global Cognitive and Memory Enhancer Drugs Sales by Regions
        2.2.2 Global Cognitive and Memory Enhancer Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Cognitive and Memory Enhancer Drugs Sales by Manufacturers
        3.1.1 Cognitive and Memory Enhancer Drugs Sales by Manufacturers
        3.1.2 Cognitive and Memory Enhancer Drugs Sales Market Share by Manufacturers
        3.1.3 Global Cognitive and Memory Enhancer Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Cognitive and Memory Enhancer Drugs Revenue by Manufacturers
        3.2.1 Cognitive and Memory Enhancer Drugs Revenue by Manufacturers (2016-2018)
        3.2.2 Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers (2016-2018)
    3.3 Cognitive and Memory Enhancer Drugs Price by Manufacturers
    3.4 Cognitive and Memory Enhancer Drugs Manufacturing Base Distribution, Product Types
        3.4.1 Cognitive and Memory Enhancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Cognitive and Memory Enhancer Drugs Product Category
        3.4.3 Date of International Manufacturers Enter into Cognitive and Memory Enhancer Drugs  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Cognitive and Memory Enhancer Drugs Sales by Type
    4.2 Global Cognitive and Memory Enhancer Drugs Revenue by Type
    4.3 Cognitive and Memory Enhancer Drugs Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Cognitive and Memory Enhancer Drugs Breakdown Data by Application

6 North America
    6.1 North America Cognitive and Memory Enhancer Drugs by Countries
        6.1.1 North America Cognitive and Memory Enhancer Drugs Sales by Countries
        6.1.2 North America Cognitive and Memory Enhancer Drugs Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Cognitive and Memory Enhancer Drugs by Type
    6.3 North America Cognitive and Memory Enhancer Drugs by Application
    6.4 North America Cognitive and Memory Enhancer Drugs by Company

7 Europe
    7.1 Europe Cognitive and Memory Enhancer Drugs by Countries
        7.1.1 Europe Cognitive and Memory Enhancer Drugs Sales by Countries
        7.1.2 Europe Cognitive and Memory Enhancer Drugs Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Cognitive and Memory Enhancer Drugs by Type
    7.3 Europe Cognitive and Memory Enhancer Drugs by Application
    7.4 Europe Cognitive and Memory Enhancer Drugs by Company

8 Asia Pacific
    8.1 Asia Pacific Cognitive and Memory Enhancer Drugs by Countries
        8.1.1 Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Countries
        8.1.2 Asia Pacific Cognitive and Memory Enhancer Drugs Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Cognitive and Memory Enhancer Drugs by Type
    8.3 Asia Pacific Cognitive and Memory Enhancer Drugs by Application
    8.4 Asia Pacific Cognitive and Memory Enhancer Drugs by Company

9 Central & South America
    9.1 Central & South America Cognitive and Memory Enhancer Drugs by Countries
        9.1.1 Central & South America Cognitive and Memory Enhancer Drugs Sales by Countries
        9.1.2 Central & South America Cognitive and Memory Enhancer Drugs Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Cognitive and Memory Enhancer Drugs by Type
    9.3 Central & South America Cognitive and Memory Enhancer Drugs by Application
    9.4 Central & South America Cognitive and Memory Enhancer Drugs by Company

10 Middle East and Africa
    10.1 Middle East and Africa Cognitive and Memory Enhancer Drugs by Countries
        10.1.1 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Countries
        10.1.2 Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Cognitive and Memory Enhancer Drugs by Type
    10.3 Middle East and Africa Cognitive and Memory Enhancer Drugs by Application
    10.4 Middle East and Africa Cognitive and Memory Enhancer Drugs by Company

11 Company Profiles
    11.1 Pfizer Inc.
        11.1.1 Pfizer Inc. Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.1.4 Cognitive and Memory Enhancer Drugs Product Description
        11.1.5 Recent Development
    11.2 Eisai Co., Ltd.
        11.2.1 Eisai Co., Ltd. Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.2.4 Cognitive and Memory Enhancer Drugs Product Description
        11.2.5 Recent Development
    11.3 Allergan, Inc.
        11.3.1 Allergan, Inc. Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.3.4 Cognitive and Memory Enhancer Drugs Product Description
        11.3.5 Recent Development
    11.4 Novartis AG
        11.4.1 Novartis AG Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.4.4 Cognitive and Memory Enhancer Drugs Product Description
        11.4.5 Recent Development
    11.5 Shire
        11.5.1 Shire Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.5.4 Cognitive and Memory Enhancer Drugs Product Description
        11.5.5 Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.6.4 Cognitive and Memory Enhancer Drugs Product Description
        11.6.5 Recent Development
    11.7 Takeda Pharmaceutical Company Limited
        11.7.1 Takeda Pharmaceutical Company Limited Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.7.4 Cognitive and Memory Enhancer Drugs Product Description
        11.7.5 Recent Development
    11.8 AlternaScript LLC
        11.8.1 AlternaScript LLC Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.8.4 Cognitive and Memory Enhancer Drugs Product Description
        11.8.5 Recent Development
    11.9 Cephalon, Inc.
        11.9.1 Cephalon, Inc. Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.9.4 Cognitive and Memory Enhancer Drugs Product Description
        11.9.5 Recent Development
    11.10 Ceretropic.
        11.10.1 Ceretropic. Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Cognitive and Memory Enhancer Drugs
        11.10.4 Cognitive and Memory Enhancer Drugs Product Description
        11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Cognitive and Memory Enhancer Drugs Raw Material
        13.1.2 Cognitive and Memory Enhancer Drugs Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Cognitive and Memory Enhancer Drugs
    Figure Global Cognitive and Memory Enhancer Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Cognitive and Memory Enhancer Drugs Production Market Share by Types (Product Category) in 2017
    Figure Aricept Product Picture
    Table Major Manufacturers of Aricept
    Figure Exelon Product Picture
    Table Major Manufacturers of Exelon
    Figure Namenda Product Picture
    Table Major Manufacturers of Namenda
    Figure Razadyne Product Picture
    Table Major Manufacturers of Razadyne
    Figure Provigil Product Picture
    Table Major Manufacturers of Provigil
    Figure Ritalin Product Picture
    Table Major Manufacturers of Ritalin
    Figure Adderall Product Picture
    Table Major Manufacturers of Adderall
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Disease Treatment
    Figure Academic Performance
    Figure Athletic Performance
    Figure Others
    Figure Cognitive and Memory Enhancer Drugs Report Years Considered
    Figure Global Cognitive and Memory Enhancer Drugs Market Size 2016-2025 (Million US$)
    Figure Global Cognitive and Memory Enhancer Drugs Sales 2016-2025 (K Units)
    Table Global Cognitive and Memory Enhancer Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Cognitive and Memory Enhancer Drugs Sales by Regions 2016-2025 (K Units)
    Table Global Cognitive and Memory Enhancer Drugs Sales Market Share by Regions 2016-2025
    Figure Global Cognitive and Memory Enhancer Drugs Sales Market Share by Regions 2016-2025
    Figure 2017 Global Cognitive and Memory Enhancer Drugs Sales Market Share by Regions
    Table Global Cognitive and Memory Enhancer Drugs Revenue by Regions 2016-2025 (Million US$)
    Table Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Regions 2016-2025
    Figure Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Regions
    Table Global Cognitive and Memory Enhancer Drugs Sales by Manufacturers (2016-2018) (K Units)
    Table Global Cognitive and Memory Enhancer Drugs Sales Share by Manufacturers (2016-2018)
    Figure Global Cognitive and Memory Enhancer Drugs Sales Share by Manufacturers in 2017
    Table Cognitive and Memory Enhancer Drugs Revenue by Manufacturers (2016-2018) (Million US$)
    Table Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers (2016-2018)
    Figure Cognitive and Memory Enhancer Drugs Value Share by Manufacturers in 2017
    Table Global Cognitive and Memory Enhancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Cognitive and Memory Enhancer Drugs Price (2016-2018) (USD/Unit)
    Table Cognitive and Memory Enhancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Cognitive and Memory Enhancer Drugs Product Category
    Table Date of International Manufacturers Enter into Cognitive and Memory Enhancer Drugs Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Cognitive and Memory Enhancer Drugs Sales by Type (2016-2025) (K Units)
    Table Global Cognitive and Memory Enhancer Drugs Sales Share by Type (2016-2025)
    Figure Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2016-2025)
    Figure Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type in 2017
    Table Global Cognitive and Memory Enhancer Drugs Revenue by Type (2016-2025) (Million US$)
    Table Global Cognitive and Memory Enhancer Drugs Revenue Share by Type (2016-2025)
    Figure Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2016-2025)
    Figure Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type in 2017
    Table Cognitive and Memory Enhancer Drugs Price by Type 2013-2018 (USD/Unit)
    Table Global Cognitive and Memory Enhancer Drugs Sales by Application (2016-2025) (K Units)
    Table Global Cognitive and Memory Enhancer Drugs Sales Share by Application (2016-2025)
    Figure Global Sales Cognitive and Memory Enhancer Drugs Market Share by Application (2016-2025)
    Figure Global Sales Cognitive and Memory Enhancer Drugs Market Share by Application (2016-2025)
    Figure North America Cognitive and Memory Enhancer Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure North America Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Cognitive and Memory Enhancer Drugs Sales by Countries (2016-2025) (K Units)
    Table North America Cognitive and Memory Enhancer Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Cognitive and Memory Enhancer Drugs Sales Market Share by Countries
    Table North America Cognitive and Memory Enhancer Drugs Revenue by Countries (2016-2025) (Million US$)
    Table North America Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries
    Figure United States Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure United States Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Cognitive and Memory Enhancer Drugs Sales by Type (2016-2025) (K Units)
    Table North America Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 North America Cognitive and Memory Enhancer Drugs Market Share by Type
    Table North America Cognitive and Memory Enhancer Drugs Sales by Application (2016-2025) (K Units)
    Table North America Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 North America Cognitive and Memory Enhancer Drugs Market Share by Application
    Table North America Cognitive and Memory Enhancer Drugs Sales by Company (2016-2018) (K Units)
    Table North America Cognitive and Memory Enhancer Drugs Sales Market Share by Company (2016-2018)
    Figure North America Cognitive and Memory Enhancer Drugs Sales Market Share by Company in 2017
    Figure Europe Cognitive and Memory Enhancer Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Cognitive and Memory Enhancer Drugs Sales by Countries (2016-2025) (K Units)
    Table Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Countries
    Table Europe Cognitive and Memory Enhancer Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Europe Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries
    Figure Germany Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure France Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure France Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure UK Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Cognitive and Memory Enhancer Drugs Sales by Type (2016-2025) (K Units)
    Table Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Cognitive and Memory Enhancer Drugs Market Share by Type
    Table Europe Cognitive and Memory Enhancer Drugs Sales by Application (2016-2025) (K Units)
    Table Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Cognitive and Memory Enhancer Drugs Market Share by Application
    Table Europe Cognitive and Memory Enhancer Drugs Sales by Company (2016-2018) (K Units)
    Table Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Company (2016-2018)
    Figure Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Company in 2017
    Figure Asia Pacific Cognitive and Memory Enhancer Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Countries
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries
    Figure China Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure China Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure India Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Cognitive and Memory Enhancer Drugs Market Share by Type
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Cognitive and Memory Enhancer Drugs Market Share by Application
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Company in 2017
    Figure Central & South America Cognitive and Memory Enhancer Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales by Countries (2016-2025) (K Units)
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Cognitive and Memory Enhancer Drugs Sales Market Share by Countries
    Table Central & South America Cognitive and Memory Enhancer Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries
    Figure Brazil Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales by Type (2016-2025) (K Units)
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Cognitive and Memory Enhancer Drugs Market Share by Type
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales by Application (2016-2025) (K Units)
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Cognitive and Memory Enhancer Drugs Market Share by Application
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales by Company (2016-2018) (K Units)
    Table Central & South America Cognitive and Memory Enhancer Drugs Sales Market Share by Company (2016-2018)
    Figure Central & South America Cognitive and Memory Enhancer Drugs Sales Market Share by Company in 2017
    Figure Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Countries
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Market Share by Countries
    Figure GCC Countries Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Cognitive and Memory Enhancer Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Cognitive and Memory Enhancer Drugs Market Share by Type
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Cognitive and Memory Enhancer Drugs Market Share by Application
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Company in 2017
    Table Pfizer Inc. Company Details
    Table Pfizer Inc. Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Pfizer Inc. Recent Development
    Table Eisai Co., Ltd. Company Details
    Table Eisai Co., Ltd. Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Eisai Co., Ltd. Recent Development
    Table Allergan, Inc. Company Details
    Table Allergan, Inc. Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Allergan, Inc. Recent Development
    Table Novartis AG Company Details
    Table Novartis AG Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Novartis AG Recent Development
    Table Shire Company Details
    Table Shire Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Shire Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Johnson & Johnson Recent Development
    Table Takeda Pharmaceutical Company Limited Company Details
    Table Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Takeda Pharmaceutical Company Limited Recent Development
    Table AlternaScript LLC Company Details
    Table AlternaScript LLC Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table AlternaScript LLC Recent Development
    Table Cephalon, Inc. Company Details
    Table Cephalon, Inc. Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Cephalon, Inc. Recent Development
    Table Ceretropic. Company Details
    Table Ceretropic. Cognitive and Memory Enhancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Ceretropic. Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Cognitive and Memory Enhancer Drugs Value Chain
    Table Typical Suppliers of Key Cognitive and Memory Enhancer Drugs Raw Material
    Table Cognitive and Memory Enhancer Drugs Customers List
    Table Cognitive and Memory Enhancer Drugs Sales Channels
    Table Cognitive and Memory Enhancer Drugs Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

03-Dec-2018 | Technology

Don’t await a 5G iPhone on or before 2020

Apple’s timeline for adopting the next generation of cellular connectivity, 5G, by suggesting the first compatible iPhone won’t come before 2020. Earlier rumors and reports pointed to t ...

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...